Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in CLDI — Calidi Biotherapeutics, Inc.

CIK 1214717 BOSTON, MA
Back to CLDI Full portfolio

Position in CLDI

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$19,473
+$4,412 QoQ
Shares Held
7,159
+81.7% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 23 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CLDI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,296,497 across 521 Biotechnology names. CLDI ranks #500 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in CLDI

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,473 114,550
2026-03-31 $15,061 63,019
2025-12-31 $49,056 41,929
2025-09-30 $44,984 29,595
2025-06-30 $53,491 232,576
2025-03-31 $142,584 251,916
2024-12-31 $184,019 160,018
2024-09-30 $45,157 39,612
2024-03-31 $60,517 107,110
2023-12-31 $154,379 102,238